Mainz Biomed N.V. announced a strategic partnership with labor team w ag, a diagnostic laboratory based in Goldach, Switzerland. This collaboration marks Mainz Biomed’s initial entry into the Swiss market with its ColoAlert DNA-based colorectal cancer (CRC) screening test.
The introduction of ColoAlert aims to address the urgent need for early detection and prevention in Switzerland, where thousands of new CRC cases are diagnosed annually. This innovative DNA-based screening test offers a transformative opportunity to increase participation rates in screening programs.
The partnership combines Mainz Biomed’s expertise in DNA-based diagnostics with labor team w’s strong track record in high-quality laboratory services. ColoAlert will be available through labor team w’s extensive network of healthcare providers starting in the spring of 2025, further expanding Mainz Biomed's European market presence.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.